Insider Transactions in Q3 2021 at X Biotech Inc. (XBIT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,558
-0.46%
|
$241,254
$13.07 P/Share
|
|
Sep 29
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,396
-0.4%
|
$213,148
$13.41 P/Share
|
|
Sep 28
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,263
-0.15%
|
$87,682
$14.27 P/Share
|
|
Sep 27
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
29,890
-0.73%
|
$418,460
$14.81 P/Share
|
|
Sep 24
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,418
-0.28%
|
$159,852
$14.49 P/Share
|
|
Sep 23
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,892
-0.24%
|
$138,488
$14.68 P/Share
|
|
Sep 22
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,669
-0.47%
|
$295,035
$15.14 P/Share
|
|
Sep 21
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,860
-0.41%
|
$252,900
$15.24 P/Share
|
|
Sep 20
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,471
-0.32%
|
$202,065
$15.06 P/Share
|
|
Jul 14
2021
|
John Simard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.18%
|
$900,000
$18.15 P/Share
|
|
Jul 09
2021
|
Donald H. Mac Adam |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$40,000
$4.4 P/Share
|
|
Jul 09
2021
|
Peter Libby |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$175,000
$7.76 P/Share
|